WEINRAUCH STEVE sold $147K of TRUP

WEINRAUCH STEVE (EVP, North Am & Vet Strategy) sold 6,674 shares of TRUPANION, INC. (TRUP) at $22.00 ($0.15M total) on 2026-06-05.

Original reporting
SEC EDGAR · WEINRAUCH STEVE
Published Jun 9, 2026, 11:28 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 9, 2026, 11:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TRUP
Neutral
high confidence
Mentioned
$TRUP
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRUPNeutralLow
01

Why it matters

The newest fact is the officer’s open-market sale amount, which may slightly affect sentiment but does not, by itself, change the company’s operating outlook.

02

Market read

Traders may note the insider sale as a minor sentiment datapoint, but there is no accompanying fundamental news in the text.

03

What to watch

The article provides only one sale transaction size and price; it does not include prior insider activity trends, option exercises, or broader ownership changes that would contextualize signal strength.

Relevance 4/10Novelty 2/10Timing: Filed 2026-06-09; sale executed 2026-06-05.

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for TRUPANION, Inc.

Company-level read

Ticker impact

$TRUPNeutralHigh confidence
Context

SEC Form 4 shows TRUPANION EVP Steve Weinrauch sold 6,674 shares (~$146,828) on 2026-06-05 via open-market sale.

Expected impact

Likely minimal near-term price impact; any effect would be sentiment/positioning rather than fundamentals.

Evidence & confidence

The filing is a disclosed open-market sale by an officer, with no 10b5-1 plan and no accompanying operational/regulatory news in the text.

Market effects

No sector-level read-through provided; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs; without a 10b5-1 plan, the sale still may not imply negative fundamentals.

Key entities

  • TRUPANION, INC.

    Company whose insider transaction is disclosed on SEC Form 4.

  • WEINRAUCH STEVE

    EVP, North Am & Vet Strategy; reported open-market sale of TRUP shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TRUPMedAI 8/10

Why is Trupanion (TRUP) stock soaring today

Trupanion (TRUP) shares rose 6.5% after reporting Q3 2026 revenue of $405.6M, up 10.5% YoY, and EPS of $0.21, both exceeding estimates. The company also reported strong cash flow and share repurchases. The stock has been volatile, with a 52-week low reached after a Q4 2025 EPS miss.

$TRUPHighAI 8/10

Trupanion Q3 Earnings Call Highlights

Trupanion (TRUP) expects double-digit veterinary cost inflation through 2027, with stable rate increases supporting retention. Q3 costs for paying veterinary invoices were $200.6M (69.7% of revenue). Full-year 2026 revenue is projected at $1.59B-$1.597B, with Q4 revenue expected at $407M-$414M. The company repurchased 830,000 shares for $25M and plans new digital insurance and pet food offerings.

$TRUPMed

Trupanion Inc (TRUP) Q3 2026 Earnings Call Highlights: Record Adjusted Operating Income

Trupanion Inc (TRUP) reported Q3 2026 earnings with record adjusted operating income of $47M, up 15% YoY. Net new pet additions rose 28% YoY to over 20,500, while acquisition cost per pet declined. Retention improved to 98.38%, and free cash flow hit $28.5M. The company is investing in growth initiatives like Landspath pet food, expected to launch in 2027. Challenges include elevated veterinary industry inflation and increased fixed expenses.

$TRUPHigh

Trupanion Reports Third Quarter 2026 Results

TRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Trupanion Reports Third Quarter 2026 Results SEATTLE, WA. November 5, 2026 -- Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the third quarter ended September 30, 2026. “Our third-quart

$TRUPMedAI 8/10

Property & Casualty Insurance Stocks Q2 Results: Benchmarking Trupanion (NASDAQ:TRUP)

Essent Group (ESNT) reported Q2 revenues of $362.7M, up 13.6% YoY, beating estimates. Radian Group (RDN) reported $580.7M in revenues, up 95.7% YoY, but missed EPS estimates. Fidelity National Financial (FNF) reported $4.05B in revenues, up 11.4% YoY, beating estimates. W. R. Berkley (WRB) reported $3.72B in revenues, up 1.2% YoY, missing revenue estimates but beating EPS estimates.